Delivery Order SPE2DB22D1017-SPE2DB24FF7VL
Award Date
5/17/24
Potential Completion Date
5/20/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablet products to the Defense Logistics Agency (DLA). The contract, valued at $2,067.49, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor with significant experience in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The contract is a...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets from Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,175.13 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $6,511.08, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablet units to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 18, 2023, with a ceiling value of $2,563.80 and a completion date of September 19, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC,...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablet medication to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,425.60. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The $9,845.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.30 and a final completion date of December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. This contract is not designated with any set-aside requirements,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,765.24, has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablet units to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $6,131.50, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a major...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, on September 17, 2024 for a firm fixed price of $1,558.81. The contract has a completion date of September 18, 2024 and does not have a set-aside designation. AmerisourceBergen holds several substantial Indefinite Delivery Contracts (IDCs) with federal...